MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mlinar, B.
Right arrow Articles by Enyeart, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mlinar, B.
Right arrow Articles by Enyeart, J. J.

Identical inhibitory modulation of A-type potassium currents by dihydropyridine calcium channel agonists and antagonists

B Mlinar and JJ Enyeart

Department of Pharmacology, Ohio State University College of Medicine, Columbus 43210-1239.

We have studied the interaction of dihydropyridine (DHP) Ca2+ channel agonists and antagonists with A-type K+ channels in whole-cell patch- clamp recordings from bovine adrenal zona fasciculata cells. At concentrations from 1 to 100 microM, DHP antagonists [nimodipine and (+)-Bay K 8644] and agonists [(-)-Bay K 8644 and RS 30026] each reversibly reduced A-type K+ current (IA) amplitude and markedly accelerated the apparent rate of IA inactivation. Unlike their actions on Ca2+ channels, the effects of DHP agonists and antagonists on IA were qualitatively indistinguishable. Inhibition of IA by DHPs was not accompanied by changes in the voltage-dependent steady state inactivation of IA or the kinetics of recovery subsequent to repolarization. The effects of DHPs on peak IA and inactivation kinetics were not use dependent. The DHPs were much less effective in cells where fast N-type inactivation had spontaneously diminished with time. These actions of DHPs on IA are in marked contrast to their voltage-dependent modulation of L-type Ca2+ currents, indicating that fundamentally different mechanisms are involved. Rather than directly occluding A-type K+ channels, the drugs may enhance the voltage- independent rate of inactivation. This could occur through interaction of the DHP with a site on the amino-terminal inactivation domain or the DHP binding site at the inner mouth of the channel. Regardless of the mechanism involved, the identical modulation by DHP agonists and antagonists is a distinctive feature of A-type K+ channels in adrenal zona fasciculata cells.

Volume 46, Issue 4, pp. 743-749, 10/01/1994
Copyright © 1994 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Neurophysiol.Home page
M. Shah and D. G. Haylett
Ca2+ Channels Involved in the Generation of the Slow Afterhyperpolarization in Cultured Rat Hippocampal Pyramidal Neurons
J Neurophysiol, May 1, 2000; 83(5): 2554 - 2561.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. C. Gomora, J. A. Enyeart, and J. J. Enyeart
Mibefradil Potently Blocks ATP-Activated K+ Channels in Adrenal Cells
Mol. Pharmacol., December 1, 1999; 56(6): 1192 - 1197.
[Abstract] [Full Text]


Home page
Mol Hum ReprodHome page
L. O. Goodwin, N. B. Leeds, D. Guzowski, I. R. Hurley, R. G. Pergolizzi, and S. Benoff
Identification of structural elements of the testis-specific voltage dependent calcium channel that potentially regulate its biophysical properties
Mol. Hum. Reprod., April 1, 1999; 5(4): 311 - 322.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
L. M. Hurley and K. Graubard
Pharmacologically and Functionally Distinct Calcium Currents of Stomatogastric Neurons
J Neurophysiol, April 1, 1998; 79(4): 2070 - 2081.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1994 by the American Society for Pharmacology and Experimental Therapeutics